101 
There have been new features added to the BioInvest website – especially for logged in users. They include:
- Community overall But/Sell sentiment for eth BioMecial sector by monitoring all summed POLL votes for BUY and sell (plotted daily for 3 months so possible trends can be seen)
- On log-in you see a listing of the stock that has been voted the strongest Buy
…
 |
There have been new features added to the BioInvest website – especially for l…
|
 |
Viralytics - well positioned with a Phase II about to begin
Is Viralytics well positioned with a Phase II about to begin considering its rival coampnies with similar approaches yet different viruses have market caps between $150M to 200M with Phase II & Phase III candidates. Also does anyone have insight into Viralytics likely relase date of its current Phase I trials re head and neck & breast cance?
|
 |
Pharmaxis trading halt & 40% stock price drop
Pharmaxis is in a trading halt as of today. Does anyone know why?
|
 |
Avexa - buy or sell now that it has given up on its drug?
Given AVX is down almost 80% does anyone feel it should be a buy or sell now that it has given up on its drug? It market cap has dropped to be approximately what its cash position is. Should any worth be placed on the drug candiddate and the data they generated?
|
 |
Pharmaxis has started to move up
Pharmaxis has started to move up – is this in relation to their expected cystic fibrosis phase II trial announcement? And when is this announcement likely?
|
 |
Hospital reform & funding
The impact on the Rudd reform on hospital healthcare provider companies? An improvement, drag down, interruption while budgets are assessed or will the increasing demand of the ageing population and healthcare power the industry on regardless?
|
|
|
Will biotechs get hit hard if the market does a dip on a "w" as per th…
In almost all major market drops the recovery has not been a "V" but a "W" and in the time space of 6 months to 2 years from the low point - meaning markets would predicatbly go south again if one looks at history. The drop for biotechs as the GFC unfloded was greater than the general markets. Will biotechs get hit hard again if the market does a dip on a "w" as per t…
|
|
|
Thoratec competition with Sunshine Heart and comparison
Thoratec has a much larger market cap than Sunshine Heart and in comparison has a riskier device in my opinion (being blood contacting). Also some comments by brokers suggest that Thortace shares could be even higher given the potential of this market. I am an investor of Sunshine Heart.
|
|
|
Pharmaxis approaching new milestones
Pharmaxis getting closer to further achievements which provides an incentive to purchase and hold for these announcements. This time period puts an added insurance for these shares to at least hold their value, as i also have concerns that the market could go south due to a 'W' occurring?
Its a good time to purchase stocks that have added value about to occur given p[ossible "… |
|
|
Pharmaxis has begun its run up again?
Has Pharmaxis has begun its run up again with Aust. approval soon for bronchetasis & cystic fibrosis data next year? I am a holder of PXS stock.
|
Terms & Rules
As per ASIC Regulatory Guide 162: All investment tips and comments appearing on this website (Poll results, BLOGS & discussion forums) are submitted by the general public who are not licensed financial advisors. None of the information on this website is financial or investment advice, you should seek independent financial or investment advice by a licensed financial or investment advisor before entering into any position of financial risk. Before using this website, you must agree to the BioInvesting.com.au Terms Of Use